Intracoronary thrombolysis and coronary angioplasty are widely performed for restoring coronary flow to the jeopardized myocardium in patients with acute myocardial infarction.1 Coronary reflow, if achieved in the early stage of infarction, may limit the progression of myocardial necrosis and should enhance the functional recovery of postischemic myocardium.2-4 The extent to which coronary reperfusion salvages the function of severely ischemic myocardium is of clinical importance but remains controversial because the identification and quantification of the risk area in the acute phase of infarction has been difficult in patients with conventional methods. The risk area obviously varies among patients even with the same occlusion site in the same coronary artery; therefore, analysis of changes in infarct size and regional function after reperfusion is meaningful only if examined in relation to the initial risk area.
The purpose of this study was to investigate the beneficial effect of early coronary reperfusion on myocardial salvage and to elucidate the process of functional recovery of postischemic myocardium within the risk area in patients with reperfused anterior infarction. In this study, myocardial contrast echocardiography (MCE) was used to determine the risk area as an area of contrast perfusion defect5-7 in the acute stage of infarction. Then, regional contraction in the risk area was serially assessed with echocardiographically determined endocardial length of abnormal contractile segment within the risk area. The results were also compared between reperfused patients and nonreperfused patients to clarify the beneficial effect of These echo images were recorded on the same videocassettes. We referred to the initial echo images before each echo examination in order to depict the same echo view insofar as possible.
Coronary angiography was repeated 28 days (range, 24-31 days) after the onset of myocardial infarction. All patients who achieved coronary reflow exhibited no significant progression of stenosis in the infarct-related artery as well as in the other coronary arteries.
Data Analysis
Apical long-axis views were analyzed for assessment of risk area and for analysis of regional wall motion. Since no contrast enhancement was observed in this image after contrast injection into the right coronary artery, only contrast images obtained after contrast injection into the left coronary artery were used for analysis. The risk area was determined in the end-diastolic frame of the postinjection cycle showing the best delineation between contrast-enhanced and non-contrast-enhanced myocardium. The risk area was defined as an area not showing contrast enhancement ( Figure  1) . A commercially available image analyzer (model LA-500, PIAS, Osaka) was used to measure the endocardial length of the contrast defect segment for the quantification of the size of the risk area.
Abnormal contraction was defined as akinesis or dyskinesis, showing no inward endocardial motion during systole9 (Figure 2 ). The endocardial length of the end-diastolic segment showing dyskinesis/akinesis was measured in each follow-up echo study. Recovery of wall motion within the risk area was assessed with the ratio of the endocardial length of the abnormal contractile segment to that of the contrast defect segment (AS/CD) at each study. The AS/CD at 28 days of reperfusion was used to assess the extent of myocardial necrosis in the risk area.
Analysis of Catheterization Data
The right anterior oblique view of left ventriculograms obtained shortly after infarction and 4 weeks later were used for the determination of end-diastolic volume and ejection fraction. End-diastolic and endsystolic endocardial contours were traced in the frames with maximum and minimum volumes, respectively. Left ventricular end-diastolic volume (LVEDV) was calculated by the area-length method and was divided by the body surface area to determine LVEDV index (LVEDVI, in milliliters per square meter). Left further statistically significant reduction in AS/CD was observed after day 14 (0.72±0.10 at day 28).
In eight patients reperfused within 4 hours of onset, the reduction in AS/CD appeared to be more rapid and greater than in those reperfused later than 4 hours. The relation between elapsed time and infarct size within the risk area, expressed by AS/CD at day 28, is shown in Figure 4 . The value for AS/CD at day 28 in patients reperfused within 4 Pr-Re~bw hours (85 + 18 versus 111±38 ml/m2), but the difference was not significant. There was also no difference in LVEF at baseline study between the two groups. The patients reperfused within 4 hours showed significant improvement in this parameter from the base to the delayed studies (50±8% versus 59±10%, p<0.05) and showed significantly better global function in the delayed study compared with those reperfused later than 4 hours (p<0.05).
Patency of Infarct-Related Artery and Infarct Size
To assess the beneficial effect of coronary reflow on infarct size, we compared the ratio of the infarct size to the size of the risk area between 21 reperfused patients and 10 nonreperfused patients with persistent occlusion of the infarct-related artery. Since MCE was not performed in 10 nonreperfused patients, we measured the lengths of segments showing abnormal contraction at days 1 and 28 of infarction to determine the segment length ratio (AS-28/AS-1). As shown in our results, the endocardial length of the contrast defect was almost compatible with that of the abnormal contraction segment before reflow. Values for AS-28/AS-1 in reperfused patients were significantly lower than those in the nonreperfused patients (0.73±0.11 versus 0.93±0.08; p<O.Ol) (Figure 6 ). Although the value of AS-28/AS-1 was <0.9 in each reperfused patient, three of 10 nonreperfuseod patients showed AS-28/AS-1 >1.0, indicating the progression of the infarct expansion.
Discussion
The beneficial effect of coronary reflow on myocardial salvage should be more accurately determined than in the previous studies if the size of the risk area is measured, regardless of the occlusion site of the coronary artery. In this study, the risk area was defined before reflow with MCE to assess the time course of Although it is well known that early coronary reflow is promising in salvage of the jeopardized myocardium,2-4 the extent to which the ischemic myocardium can be salvaged within the risk area remains to be solved. The size of the risk area should vary among individuals even with coronary occlusion at the apparently comparable level of the same vessel. Therefore, analysis of changes in the infarct size and regional function is meaningful only if examined in relation to the initial risk area. In this study, we assessed the infarct size as a ratio to the size of the risk area. In patients who achieved reflow, AS/CD at day 28 was significantly reduced, by an average of 28%, compared with the value at day 1. Moreover, the extent of abnormal contraction was significantly lower than in those with persistent coronary occlusion. Therefore, if the size of the risk area is taken into consideration, timely coronary reperfusion (<6 hours) has a beneficial effect on the salvage of a significant amount of the postischemic myocardium, i.e., an average of 28% of the risk area.
In a canine experiment, Ellis et a112 demonstrated risk was reduced from 89.1% to 23.9% in the reperfused group when reperfusion was carried out 2 hours after coronary occlusion. In their study, a greater amount of the myocardium (>70%) can be salvaged by coronary reflow compared with the results of this study (average, 28%). In addition to species difference, several other factors may explain these differences. In clinical settings, at least 2-4 hours has usually passed by the time of restoration of coronary reflow by intracoronary thrombolysis and/or coronary angioplasty. Whereas they determined the size of myocardial necrosis using a histological approach, we assessed the size of infarction with the extent of wall motion abnormalities relative to that of the risk area.
The earlier coronary reflow is considered to be preferable in limiting the infarct size. In the present study, AS/CD at day 28 and LVEF were significantly lower in patients reperfused within 4 hours of onset than in those reperfused later than 4 hours. These results are in accordance with those of previous studies.14,15 Moreover, changes in AS/CD demonstrated that major improvement in regional function is accomplished within 3 days in more than half of the patients reperfused within 4 hours. Thus, the earlier the coronary reflow is achieved, the larger the amount of jeopardized myocardium that can be salvaged and the more rapidly improvement in regional function may be obtained.
Collaterals play an important role in the attenuation of the infarct size. Sabia et a116 assessed the functional significance of collaterals by MCE in patients with recent acute myocardial infarction (12±7 days after onset). They indicated that collateral perfusion territory was visualized by extensive "positive" contrast area and that these collateral flows were effective in the preservation of the perfusion territory. In this study, however, no patients studied showed collateral perfusion in the apical long-axis view during contrast injection into the right coronary artery before reflow. Several factors may explain these differences: 1) MCE was performed in the very early stage of infarction (within 6 hours of the onset), and 2) the patients we studied exhibited angiographically none or poor collaterals. This poor development of collateral channels is likely to account for the small variability in AS/CD on the day of infarction. In patients with well-developed collateral channels that come from the right coronary artery, the risk area, defined as an area of contrast defect, may be overestimated with the use of contrast injection only into the left coronary artery, and the discrepancy between the size of the contrast defect segment and that of the abnormal contractile segment should become evident.
Identification of the Risk Area
Previous studies demonstrated the usefulness and accuracy of MCE in the determination of perfusion territory of the coronary artery as well as the risk area. [5] [6] [7] [8] 15, [17] [18] [19] [20] [21] In patients with critical residual coronary stenosis, the myocardial contraction within the risk area may be depressed even after reperfusion, and this functionally depressed myocardium is called "hibernating myocardium." This abnormal contractile segment should not simply be regarded as an area of myocardial infarction. In this study, however, patients with TIMI grades 0, 1, and 2 residual stenosis were excluded, and no patients showed reocclusion of the infarct-related artery in the convalescent stage.
In patients with occlusions in other than the left anterior descending coronary artery, we cannot define the risk area as an area of contrast defect. Thus, we excluded patients with multivessel disease from the study population.
It Is well known that necrosis progresses from the endocardium to epicardium (wave-front phenomenon), and coronary reflow stops this progression of necrosis. For this reason, looking only at the endocardial motion does not seem to be sufficient for the quantification of myocardial salvage (especially extent of epicardial salvage). However, the transmural extent of necrosis may be different within the risk area. In the region of less transmural damage, endocardial motion should improve in the convalescent stage because of relatively preserved contractile function of epicardium. Therefore, the assessment of recovery of endocardial motion may well provide estimates of the amount of myocardial salvage.
Shrinkage of the infarct scar may possibly contribute to the decrease in abnormal contractile segment relative to contrast defect segment. However, we could not quantify the amount of shrinkage in our patients.
Clinical Implications
Coronary blood flow may be augmented by intraaortic balloon pumping or administration of vasodilators or free radical scavengers,24'25 and the augmentation may be associated with the increased contractile function of the stunned myocardium. However, whether these interventions enhance the rate of functional improvement of the postischemic myocardium and augment the extent of myocardial salvage remains to be seen. Little information has been available on serial changes in regional myocardial function after myocardial reperfusion in humans. This study provides important baseline data for future studies to evaluate the interventions of maximizing the rate and magnitude of improvement in the stunned myocardium after reperfusion.
Several drugs aimed at reduction of infarct size have been investigated in experimental as well as clinical studies. In clinical settings, regional and/or global left ventricular wall motion has been analyzed for evaluation of the effects of such drugs. However, it would be meaningful only if these data were analyzed in relation to the initial infarct size, particularly because the initial risk area varies greatly among patients. The current method should be useful for the evaluation of the effect of drug interventions on the extent of myocardial salvage in the risk area.
